Familial hyperaldosteronism.
Aldosterone, the major circulating mineralocorticoid, participates in blood volume and serum potassium homeostasis. Primary aldosteronism is a disorder characterised by hypertension and hypokalaemia due to autonomous aldosterone secretion from the adrenocortical zona glomerulosa. Improved screening techniques, particularly application of the plasma aldosterone:plasma renin activity ratio, have led to a suggestion that primary aldosteronism may be more common than previously appreciated among adults with hypertension. Glucocorticoid-remediable aldosteronism (GRA) was the first described familial form of hyperaldosteronism. The disorder is characterised by aldosterone secretory function regulated chronically by ACTH. Hence, aldosterone hypersecretion can be suppressed, on a sustained basis, by exogenous glucocorticoids such as dexamethasone in physiologic range doses. This autosomal dominant disorder has been shown to be caused by a hybrid gene mutation formed by a crossover of genetic material between the ACTH-responsive regulatory portion of the 11ss-hydroxylase (CYP11B1) gene and the coding region of the aldosterone synthase (CYP11B2) gene. Familial hyperaldosteronism type II (FH-II), so named to distinguish the disorder from GRA or familial hyperaldosteronism type I (FH-I), is characterised by autosomal dominant inheritance of autonomous aldosterone hypersecretion which is not suppressible by dexamethasone. Linkage analysis in a single large kindred, and direct mutation screening, has shown that this disorder is unrelated to mutations in the genes for aldosterone synthase or the angiotensin II receptor. The precise genetic cause of FH-II remains to be elucidated.
Torpy
D J
DJ
Department of Medicine, Greenslopes Hospital, University of Queensland, Brisbane, Australia.
Stratakis
C A
CA
Chrousos
G P
GP
D019405:Cytochrome P-450 CYP11B2 / Q000235:genetics; D006801:Humans; D006929:Hyperaldosteronism / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D006973:Hypertension / Q000209:etiology; D007008:Hypokalemia / Q000209:etiology; D013252:Steroid 11-beta-Hydroxylase / Q000235:genetics
D019405:Cytochrome P-450 CYP11B2; D013252:Steroid 11-beta-Hydroxylase